← Back to Clinical Trials
Recruiting NCT06994793

NCT06994793 Validity and Reliability of Gait and Jump Parameters Measured by the iSen Device in Healthy Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06994793
Status Recruiting
Phase
Sponsor Kırıkkale University
Condition Healthy Adults
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2025-01-10
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2025-01-10 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the validity and reliability of gait and jumping parameters measured with the iSen device in healthy adults. Gait analysis is a valuable tool for assessing general health, cognitive performance, quality of life, and mortality. It is commonly used by clinicians to assess functional limitations resulting from neurological or orthopedic conditions and to guide treatment plans. Traditional gait assessments primarily focus on walking speed, but additional parameters such as step length, step time, and gait symmetry are crucial for a comprehensive analysis. The study will also assess vertical jump performance, which is a surrogate measure of explosive lower limb strength and is commonly used in sports performance and injury prediction. The iSen device, a wearable and affordable sensor, will be compared to the validated BTS G-Walk system to evaluate the accuracy and consistency of its measurements. Participants aged 18-35 with no history of musculoskeletal, neurological, or systemic conditions will be included. The study will be conducted at Gazi University and Kırıkkale University, where participants will undergo assessments of gait and jump performance using both iSen and BTS G-Walk devices. A test-retest reliability protocol will be employed with a seven-day interval between measurements. The results will provide evidence on the suitability of the iSen device for reliable and valid gait and jump measurements in clinical settings

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 35 years. Voluntarily agree to participate in the study. No history of surgery in the lower extremities. Exclusion Criteria: * Any musculoskeletal, neurological, or systemic pathology that could affect gait or jumping performance. Inability to comply with study procedures.

Contact & Investigator

Central Contact

Saniye AYDOGAN ARSLAN

✉ fztsaniye1982@gmail.com

📞 +905053333457

Frequently Asked Questions

Who can join the NCT06994793 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06994793 currently recruiting?

Yes, NCT06994793 is actively recruiting participants. Contact the research team at fztsaniye1982@gmail.com for enrollment information.

Where is the NCT06994793 trial being conducted?

This trial is being conducted at Kirikkale, Turkey (Türkiye).

Who is sponsoring the NCT06994793 clinical trial?

NCT06994793 is sponsored by Kırıkkale University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology